CoChat

A Randomized Controlled Trial of Cognitive Behavioral Therapy for Adherence and Depression (CBT-AD) in Patients With Uncontrolled Type 2 Diabetes

Open access
Safren, Steven A., Gonzalez, Jeffrey S., Wexler, Deborah J., Psaros, Christina, Delahanty, Linda M., Blashill, Aaron J., Margolina, Aleksandra I., Cagliero, Enrico · 2014 · Diabetes Care
Cited by 229

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: To test cognitive behavioral therapy for adherence and depression (CBT-AD) in type 2 diabetes. We hypothesized that CBT-AD would improve adherence; depression; and, secondarily, hemoglobin A1c (A1C). RESEARCH DESIGN AND METHODS: Eighty-seven adults with unipolar depression and uncontrolled type 2 diabetes received enhanced treatment as usual (ETAU), including medication adherence, self-monitoring of blood glucose (SMBG), and lifestyle counseling; a provider letter documented psychiatric diagnoses. Those randomized to the intervention arm also received 9–11 sessions of CBT-AD. RESULTS: Immediately after acute treatment (4 months), adjusting for baseline, CBT-AD had 20.7 percentage points greater oral medication adherence on electronic pill cap (95% CI −31.14 to −10.22, P = 0.000); 30.2 percentage points greater SMBG adherence through glucometer downloads (95% CI −42.95 to −17.37, P = 0.000); 6.44 points lower depression scores on the Montgomery-Asberg Depression Rating Scale (95% CI 2.33–10.56, P = 0.002); 0.74 points lower on the Clinical Global Impression (95% CI 0.16–1.32, P = 0.01); and 0.72 units lower A1C (95% CI 0.29–1.15, P = 0.001) relative to ETAU. Analyses of 4-, 8-, and 12-month follow-up time points indicated that CBT-AD maintained 16.3 percentage points higher medication adherence (95% CI −26.1 to −6.5, P = 0.001); 22.3 percentage points greater SMBG adherence (95% CI −36.1 to −8.6, P = 0.002); and 0.63 units lower A1C (95% CI 0.06–1.2, P = 0.03) after acute treatment ended. For depression, there was some evidence of continued improvement posttreatment, but no between-group differences. CONCLUSIONS: CBT-AD is an effective intervention for adherence, depression, and glycemic control, with enduring and clinically meaningful benefits for diabetes self-management and glycemic control in adults with type 2 diabetes and depression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc13-0816

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 23

  1. Hoerger, 2008, Is glycemic control improving in U.S. adults?, Diabetes Care, 31, 81, 10.2337/dc07-1572 · DOI · Paper page
  2. Donnan, 2002, Adherence to prescribed oral hypoglycaemic medication in a population of patients with type 2 diabetes: a retrospective cohort study, Diabet Med, 19, 279, 10.1046/j.1464-5491.2002.00689.x · DOI · Paper page
  3. Ali, 2006, The prevalence of co-morbid depression in adults with type 2 diabetes: a systematic review and meta-analysis, Diabet Med, 23, 1165, 10.1111/j.1464-5491.2006.01943.x · DOI · Paper page
  4. Lustman, 2000, Depression and poor glycemic control: a meta-analytic review of the literature, Diabetes Care, 23, 934, 10.2337/diacare.23.7.934 · DOI · Paper page
  5. Lin, 2009, Depression and increased mortality in diabetes: unexpected causes of death, Ann Fam Med, 7, 414, 10.1370/afm.998 · DOI · Paper page
  6. Williams, 2004, The effectiveness of depression care management on diabetes-related outcomes in older patients, Ann Intern Med, 140, 1015, 10.7326/0003-4819-140-12-200406150-00012 · DOI · Paper page
  7. Katon, 2004, The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression, Arch Gen Psychiatry, 61, 1042, 10.1001/archpsyc.61.10.1042 · DOI
  8. Lin, 2006, Effects of enhanced depression treatment on diabetes self-care, Ann Fam Med, 4, 46, 10.1370/afm.423 · DOI · Paper page
  9. Safren, 2009, A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals, Health Psychol, 28, 1, 10.1037/a0012715 · DOI · Paper page
  10. Safren, 2012, Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trial, J Consult Clin Psychol, 80, 404, 10.1037/a0028208 · DOI · Paper page
  11. Safren, 2007, Coping with Chronic Illness: A Cognitive-Behavioral Approach for Adherence and Depression Therapist Guide, 10.1093/med:psych/9780195315158.001.0001 · DOI
  12. Sheehan, 1998, The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10, J Clin Psychiatry, 59, 22
  13. Safren, 1999, Life-Steps: applying cognitive behavioral therapy to HIV medication adherence, Cognit Behav Pract, 6, 332, 10.1016/S1077-7229(99)80052-2 · DOI · Paper page
  14. Liu, 2001, A comparison study of multiple measures of adherence to HIV protease inhibitors, Ann Intern Med, 134, 968, 10.7326/0003-4819-134-10-200105150-00011 · DOI · Paper page
  15. Liu, 2006, Repeated measures longitudinal analyses of HIV virologic response as a function of percent adherence, dose timing, genotypic sensitivity, and other factors, J Acquir Immune Defic Syndr, 41, 315, 10.1097/01.qai.0000197071.77482.6e · DOI · Paper page
  16. Llabre, 2006, A measurement model of medication adherence to highly active antiretroviral therapy and its relation to viral load in HIV-positive adults, AIDS Patient Care STDS, 20, 701, 10.1089/apc.2006.20.701 · DOI
  17. Goodall, 1991, Self-management of diabetes mellitus: a critical review, Health Psychol, 10, 1, 10.1037/0278-6133.10.1.1 · doi:10.1037/0278-6133.10.1.1 · Paper page
  18. Kurtz, 1990, Adherence to diabetes regimens: empirical status and clinical applications, Diabetes Educ, 16, 50, 10.1177/014572179001600112 · DOI
  19. Nathan, 1984, The clinical information value of the glycosylated hemoglobin assay, N Engl J Med, 310, 341, 10.1056/NEJM198402093100602 · DOI · Paper page
  20. Singer, 1989, Tests of glycemia in diabetes mellitus. Their use in establishing a diagnosis and in treatment, Ann Intern Med, 110, 125, 10.7326/0003-4819-110-2-125 · DOI · Paper page
  21. Sherifali, 2010, The effect of oral antidiabetic agents on A1C levels: a systematic review and meta-analysis, Diabetes Care, 33, 1859, 10.2337/dc09-1727 · DOI · Paper page
  22. Bogner, 2012, Integrated management of type 2 diabetes mellitus and depression treatment to improve medication adherence: a randomized controlled trial, Ann Fam Med, 10, 15, 10.1370/afm.1344 · DOI · Paper page
  23. Lin, 2012, Treatment adjustment and medication adherence for complex patients with diabetes, heart disease, and depression: a randomized controlled trial, Ann Fam Med, 10, 6, 10.1370/afm.1343 · DOI · Paper page

Cited by

See all 229

Metadata

Authors
Safren, S. A., Gonzalez, J. S., Wexler, D. J., Psaros, C., Delahanty, L. M., Blashill, A. J., Margolina, A. I., & Cagliero, E.
Venue
Diabetes Care
Published
2014-02-11
Volume
37
Issue
3
Pages
625-633
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2159072498
Cited by
229
References
13
FWCI
13.21
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.